SLShirlene Telmos Silva de Lima

Shirlene Telmos Silva de Lima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shirlene Telmos Silva de Lima has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Kinetics of IgG-specific antibodies against chikungunya virus in a female cohort study in Brazil, 2018-2019

    by Lucas de Lima Nogueira, Lucas Romão Alves Vasconcelos, Cristiane Cunha Frota, Regis Bernardo Brandim Gomes, Clarissa Romero Teixeira, Shirlene Telmos Silva de Lima, Francisco Gustavo Silveira Correia, Paulo Rafael Cardoso de Sousa, Rafael Mota Ferreira, Francisco Marto Leal Pinheiro Junior, et al.

    The kinetics of IgG-specific antibody responses against chikungunya virus (CHIKV) is poorly understood. A total of 559 paired serum samples were collected at baseline and at first follow-up in a cohort of women aged 15-39 years from endemic areas of Fortaleza, Ceará State, following the major 2017 outbreak from February 2018 to August 2019. To estimate longitudinal seroprevalence, combining antibody markers (anti-CHIKV IgM and IgG) were screened by using enzyme-linked immunosorbent assays. We found an overall seroprevalence of 34% (190/559; 95%CI, 30.2-38.0) and 31.3% (175/559; 95%CI, 27.6-35.3) at baseline and first follow-up, respectively. Also, the distribution of seroprevalence did not differ significantly by age group [15-24 years, 35.4% (92/260); 25-39 years, 32.8% (98/299)]. Additionally, we found that median IgG level decreased over time across all age groups, and independent of prior history of symptomatic infection. We also observed four cases of seroreversion. Our findings provided valuable information regarding the decline of anti-CHIKV IgG levels in a post-epidemic scenario, highlighting the importance of serological surveillance to better understand the kinetics of antibody responses and to characterize epidemic risk.

  • Open Access

    CLINICAL, EPIDEMIOLOGICAL AND VACCINATION CHARACTERISTICS IN CHILDREN AND ADOLESCENTS OF SEVERE ACUTE RESPIRATORY SYNDROME DUE TO COVID-19 IN BRAZIL (2020 TO 2024)

    by Vânia Angélica Feitosa Viana, Silvio Alencar Cândido Sobrinho, Francisco de Sousa Júnior, José Quirino da Silva Filho, Karene Ferreira Cavalcante, Débora Bezerra Silva, Leda Maria Simões Mello, Maria Elisabeth Lisboa de Melo, Sônia Maria Santana Macêdo, Shirlene Telmos Silva de Lima, et al.

    Although less susceptible to severe forms of COVID-19, children and adolescents were also impacted by Severe Acute Respiratory Syndrome (SARS), with hospitalizations and deaths. Brazil recorded one of the highest pediatric mortality rates from COVID-19, exposing structural inequalities and failures in the healthcare system. The objective of this study was to analyze the clinical, epidemiological, and vaccination characteristics of children and adolescents with COVID-19-associated SARS in Brazil (2020–2024). This retrospective observational cohort study analyzed public data from 34,369 SARS cases, revealing disparities in the case fatality rate (CFR): the North (13.02%) and Northeast (11.6%) regions, Indigenous populations (22.54%), rural residents (14.34%), municipalities with a low human development index (9.41%), and the 15–19 age group had higher CFRs. The circulation of the Gamma and Delta variants (2021) was associated with peaks in incidence and mortality; however, during the circulation of Omicron (2022–2024), there was high incidence with reduced mortality. The sustained occupancy of pediatric intensive care units (ICUs) (25–32%) after 2022, and the significant increase in the proportion of children aged 0–4 years in ICU admissions, rising from approximately 52% in 2020–2021 to over 78% in 2024, underscores the demand for targeted strategies for the pediatric population. Comorbidities such as immunosuppression (OR: 4.44) and Down syndrome (OR: 3.13) were independent predictors of death. Vaccination demonstrated a protective effect; however, vaccination coverage was uneven: children under 5 years and the North/Northeast regions had the lowest rates. This study demonstrated that COVID-19-associated SARS in the pediatric population was marked by sociodemographic, regional, clinical, and vaccination disparities. Therefore, there is a clear need for integrated policies that include regionalized strategies for vulnerable populations, strengthening of pediatric ICUs, and equitable expansion of vaccination.

  • Open Access

    Vertical Transmission of Oropouche Virus in a Newly Affected Extra-Amazon Region: A Case Study of Fetal Infection and Death in Ceará, Brazil

    by Carlos Garcia Filho, Antônio Silva Lima Neto, Ana Maria Peixoto Cabral Maia, Luiz Osvaldo Rodrigues Silva, Robson da Costa Cavalcante, Higor da Silva Monteiro, Kamilla Carneiro Alves Marques, Rebeca de Souza Oliveira, Sami de Andrade Cordeiro Gadelha, Deborah Nunes de Melo, et al.

    The recent geographic spread of Oropouche virus (OROV), coupled with an increase in cases and the emergence of previously unrecognized severe manifestations, has raised significant public health concerns. We report the case of a 40-year-old family farmer at 31 weeks of gestation who presented with fever, myalgia, and headache. OROV infection was confirmed by RT-qPCR, followed by nucleotide sequencing and phylogenomic inference, with other infections ruled out. Initially, maternal and fetal health assessments revealed no complications. However, within a week, the patient noted decreased fetal movements, and ultrasound confirmed fetal demise. Molecular diagnostics identified OROV RNA in multiple fetal tissues, confirming vertical transmission. This case highlights the urgent need to protect pregnant women against viral vectors and include OROV into the differential diagnosis of febrile illnesses. Furthermore, it is critical to further investigate the pathogenic mechanisms of this virus, which may lead to changes in public health policies and clinical guidelines.


  • Open Access

    Reemergence of Oropouche virus between 2023 and 2024 in Brazil

    by Gabriel C. Scachetti, Julia Forato, Ingra M. Claro, Xinyi Hua, Bárbara B. Salgado, Aline Vieira, Camila L. Simeoni, Aguyda R. C. Barbosa, Italo L. Rosa, Gabriela F. de Souza, et al.

    Background: Oropouche virus (OROV; species Orthobunyavirus oropoucheense ) is an arthropod-borne virus that has caused outbreaks of Oropouche fever in Central and South America since the 1950s. This study investigates virological factors contributing to the reemergence of Oropouche fever in Brazil between 2023 and 2024. Methods: In this study, we combined OROV genomic, molecular, and serological data from Brazil from 1 January 2015 to 29 June 2024, along with in vitro and in vivo characterization. Molecular screening data included 93 patients with febrile illness between January 2023 and February 2024 from the Amazonas State. Genomic data comprised two genomic OROV sequences from patients. Serological data were obtained from neutralizing antibody tests comparing the prototype OROV strain BeAn 19991 and the 2024 epidemic strain. Epidemiological data included aggregated cases reported to the Brazilian Ministry of Health from 1 January 2014 to 29 June 2024. Findings: In 2024, autochthonous OROV infections were detected in previously non-endemic areas across all five Brazilian regions. Cases were reported in 19 of 27 federal units, with 83.2% (6,895 of 8,284) of infections in Northern Brazil and a nearly 200-fold increase in incidence compared to reported cases over the last decade. We detected OROV RNA in 10.8% (10 of 93) of patients with febrile illness between December 2023 and May 2024 in Amazonas. We demonstrate that the 2023-2024 epidemic was caused by a novel OROV reassortant that replicated approximately 100-fold higher titers in mammalian cells compared to the prototype strain. The 2023-2024 OROV reassortant displayed plaques earlier than the prototype, produced 1.7 times more plaques, and plaque sizes were 2.5 larger compared to the prototype. Furthermore, serum collected in 2016 from previously OROV-infected individuals showed at least a 32-fold reduction in neutralizing capacity against the reassortment strain compared to the prototype. Interpretation: These findings provide a comprehensive assessment of Oropouche fever in Brazil and contribute to a better understanding of the 2023-2024 OROV reemergence. The recent increased incidence may be related to a higher replication efficiency of a new reassortant virus that also evades previous immunity.


  • Open Access

    Utilidade da autópsia minimamente invasiva no diagnóstico das arboviroses para ampliação da sensibilidade do Sistema de Vigilância Epidemiológica no Brasil: experiência do Ceará

    by Livia Mendes de Almeida, Deborah Nunes de Melo, Manuella Mendonça da Silva, Pedro Mansueto Melo de Souza, Fernanda Kézia de Sousa Silva, Tania Mara Silva Coelho, Shirlene Telmos Silva de Lima, Anacelia Gomes de Matos Mota, Renata Aparecida de Almeida Monteiro, Paulo Hilario Nascimento Saldiva, et al.

    Resumo Objetivo: Estabelecer protocolo para realização de autópsias minimamente invasivas (AMIs) na detecção de óbitos por arboviroses e relatar dados preliminares desse protocolo no Ceará, Brasil. Métodos: Médicos patologistas foram treinados em AMI. Resultados: Estabeleceu-se protocolo para AMI, definindo-se critérios para amostras a serem coletadas, suas formas de armazenamento e diagnóstico, segundo o tipo de amostra biológica; em três meses, foram realizadas 43 AMIs, das quais 21 (48,8%) chegaram ao Serviço de Verificação de Óbito (SVO) com hipótese diagnóstica de alguma arbovirose e sete (16,3%) foram confirmados (seis de chikungunya; uma de dengue); também foram confirmados casos de covid-19 (n = 9), tuberculose (n = 5), meningite (n = 4), criptococose (n = 1), doença de Creutzfeldt-Jakob (n = 1), neoplasia de mama (n = 1) e raiva humana (n = 1). Conclusão: O protocolo implantado permitiu a captação de um maior número de óbitos suspeitos de arboviroses, além da confirmação de outras patologias de interesse da vigilância.

  • Open Access

    Usefulness of minimally invasive autopsy in the diagnosis of arboviruses to increase the sensitivity of the Epidemiological Surveillance System in Ceará, Brazil

    by Livia Mendes de Almeida, Deborah Nunes de Melo, Manuella Mendonça da Silva, Pedro Mansueto Melo de Souza, Fernanda Kézia de Sousa Silva, Tania Mara Silva Coelho, Shirlene Telmos Silva de Lima, Anacelia Gomes de Matos Mota, Renata Aparecida de Almeida Monteiro, Paulo Hilario Nascimento Saldiva, et al.

    Objective: To create a protocol for performing minimally invasive autopsies (MIA) in detecting deaths from arboviruses and report preliminary data from its application in Ceará state, Brazil. Methods: Training was provided to medical pathologists on MIA. Results: A protocol was established for performing MIA, defining criteria for sample collection, storage methods, and diagnoses to be carried out according to the type of biological sample; 43 MIAs were performed in three months. Of these, 21 (48.8%) arrived at the Death Verification Service (SVO) with arboviruses as a diagnostic hypothesis, and seven (16.3%) were confirmed (six chikungunya cases and one dengue case); cases of COVID-19 (n = 9), tuberculosis (n = 5), meningitis (n = 4), cryptococcosis (n = 1), Creutzfeldt-Jakob disease (n = 1), breast cancer (n = 1), and human rabies (n = 1) were also confirmed. Conclusion: The protocol implemented enabled identification of a larger number of suspected arbovirus-related deaths, as well as confirmation of other diseases of interest for surveillance.


  • Open Access

    Spatial-temporal dynamics and recurrence of chikungunya virus in Brazil

    by William M. de Souza, Shirlene T. S. Lima, Leda M. Simões Mello, Darlan S. Candido, Lewis Buss, Charles Whittaker, Ingra M. Claro, Nilani Chandradeva, Fabiana Granja, Ronaldo de Jesus, et al.

    Chikungunya virus (CHIKV) is an Aedes mosquito-borne virus that has caused explosive epidemics linked to acute, chronic, and severe clinical outcomes. Since 2014, Brazil has had the highest number of chikungunya fever (CHIKF) cases in the Americas. Here, we report and contextualize the spatiotemporal dynamic of CHIKF in Brazil and combine genomic, epidemiological, and vector analyses to investigate CHIKF recurrence in several Brazilian states. From 2013 to 2022, CHIKV caused seven epidemic waves across Brazil, affecting 59.5% (3,316 of 5,570) of the country’s municipalities. To date, Ceará State in the northeast has been the most affected, with 81,274 cases during the two largest epidemic waves in 2016 and 2017, and the ongoing third wave in 2022. The 2022 CHIKF recurrence was associated with a new introduction of an East/Central/South African strain. Also, the CHIKV recurrences in Ceará, Tocantins, and Pernambuco States were limited to municipalities with few or no prior reported cases in the previous epidemic waves, suggesting that spatial heterogeneity of CHIKV spread and population immunity may explain the recurrence pattern in the country. In addition, the population density metrics of main CHIKV vector in Brazil, Ae. aegypti , were not correlated spatially with locations of CHIKF recurrence in Ceará and Tocantins States. Also, we show that CHIKF disproportionally affected females, and we estimated the case-fatality ratio in Ceará at ∼1.3 deaths per 1,000 cases. These findings more comprehensively describe CHIKV epidemics in Brazil and contribute to understanding CHIKF recurrence in urban settings. Overall, this information may help guide public health policy to mitigate and reduce the burden of urban arboviruses.